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Abstract
Phosphoinositide-dependent kinase 1 (PDK1) plays an important role in integrating the T cell antigen receptor (TCR) and
CD28 signals to achieve efficient NF-kB activation. PDK1 is also an important regulator of T cell development, mediating pre-
TCR induced proliferation signals. However, the role of PDK1 in B cell antigen receptor (BCR) signaling and B cell
development remains largely unknown. In this study we provide genetic evidence supporting the role of PDK1 in B cell
survival. We found PDK1 is required for BCR mediated survival in resting B cells, likely through regulation of Foxo activation.
PDK1-dependent signaling to NF-kB is not crucial to resting B cell viability. However, PDK1 is necessary for triggering NF-kB
during B cell activation and is required for activated B cell survival. Together these studies demonstrate that PDK1 is
essential for BCR-induced signal transduction to Foxo and NF-kB and is indispensable for both resting and activated B cell
survival.
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Introduction
Phosphoinositide-dependent kinase 1 (PDK1) mediates signal-
ing pathways activated by various cell surface receptors, and is
important for cell metabolism, survival, and activation [1]. PDK1
possesses a pleckstrin homology (PH) domain that binds to the
second messenger PtdIns(3,4,5)P3 [1]. Thus, PDK1 is a well-
characterized downstream signaling molecule of phosphoinositide
3-kinase (PI3K) [1], although it has been suggested that PDK1 can
phosphorylate substrate without binding to PtdIns(3,4,5)P3 [2].
PDK1 may act as a ‘master regulator’ of the protein kinase A/
protein kinase G/protein kinase C (AGC) family of kinases [3].
PDK1 was initially identified as a kinase for AKT, and AKT
remains the best-characterized PDK1 substrate [3,4]. AKT
activity is regulated by phosphorylation at threonine 308 (T308)
by PDK1 [4,5] and at serine 473 (S473) by mammalian target of
rapamycin (mTOR) [6,7].
Recent studies have established that PDK1 is essential for
efficient activation of Protein kinase C h (PKC-h) by the PI3K
pathway and subsequent assembly of the CARMA1-BCL10-
MALT1 (CBM) complex to activate NF-kB during coordinated
stimulation of the T cell antigen receptor (TCR) and co-
stimulatory receptor CD28 [8]. PDK1 also plays a crucial role
in T cell development, as evidenced by the fact that conditional
deletion of PDK1 in double-negative (DN) thymocytes blocks T
cell development at the DN4 stage by impairing pre-TCR induced
proliferation [9]. Deleting PDK1 later, at the double-positive (DP)
thymocytes stage, selectively affects CD8SP thymocyte develop-
ment without altering CD4 single-positive (SP) thymocyte
development.
B cells share many features with T cells, most notably antigen
receptor triggered and developmentally regulated signaling events
(12). Both TCR and B cell antigen receptor (BCR) transmit signals
via phosphorylation of immunoreceptor tyrosine-based activation
motifs (ITAMs), although in the BCR signaling complex the
signal-transducing Iga/Igb heterodimer only contains two
ITAMs, while there are 10 ITAMs in the TCR signaling complex.
In BCR signaling, phosphorylated ITAMs mediate recruitment
and activation of downstream kinases including SYK and BTK for
BCR and Src family kinases (LYN, FYN, and BLK) for pre-BCR
[10]. These downstream kinases contribute to PI3K activation.
PI3K activation is, in turn, required for activation of NF-kB and
AKT and is, therefore, needed for B cell activation [11,12]. This
process is analogous, but not identical, to TCR-induced signaling
events. Despite several well-established differences, the ITAM-
activated molecules induce serial activation of downstream kinase
cascades, including PI3K, JNK, MAPK, PKC, and AKT, and
these events are thought to be similar in both T and B cells.
Ultimately, this results in activation of several transcription factors
(NF-kB, NF-AT, AP-1, etc.) necessary for proliferation and survival
of both B cells and T cells [13].
The NF-kB pathway affects B cell development and survival
[14]. Although it has been reported that PI3K is involved in NF-
kB activation downstream of BCR [11,12], the details of how
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BCR ligation leads to NF-kB activation through PI3K remain
unknown [11,15]. Similar to TCR signaling, activation of NF-kB
downstream of BCR depends upon a PKC isoform, PKCb [16].
Furthermore, the components of the CBM complex, CARMA1,
BCL10 and MALT1, are required for NF-kB activation by both
TCR and BCR ligation [16–18]. However, despite the clear
homology of these signaling pathways, a role for PDK1 in BCR
signaling has not been established. In the context of aberrant
signaling in lymphoma, PDK1 is essential for NF-kB activation
and survival of a diffuse large B cell lymphoma cell line that has a
mutation in the BCR proximal signaling adaptor CD79B [19].
Therefore, it is possible that PDK1 is also involved in PI3K
induced activation of PKCb, and subsequent activation of the NF-
kB pathway, through assembly and activation of the CBM
complex in B cells.
In B cells, the PI3K/NF-kB pathway has been shown to provide
signals essential for B cell development and survival. PI3K
knockout (p85a) mice show inhibition of B cell development
between the pro-B cell and pre-B cell stages, and have impaired
immune responses [20,21]. Deficiency of genes that are involved
in the NF-kB pathway has also been found to block B cell
development at various stages [22]. The NF-kB pathway regulates
expression of many genes that are essential for cell proliferation
and survival, including the BCL2 family members BCL2, BCL-xL
and Bfl-1/A1; the cell cycle genes E2Fa and cyclin E; and the
proliferation-related gene c-Myc [23]. These NF-kB target genes
have been found to regulate the survival and proliferation of B
cells at various developmental stages. Another PDK1 substrate in
B cells, AKT, is known to modulate apoptosis [24,25] and is
involved in T cell development. However, the exact role of PDK1,
a major downstream kinase of PI3K, in B cell development
remains largely unknown.
In this study, we investigated the role of PDK1 in BCR-induced
signal transduction and B cell development using both a mouse
with B-cell specific conditional deletion of Pdk1 and chemical
inhibitors of PDK1. We found that PDK1 is essential for B cell
development beyond the immature B cell stage in the bone
marrow, possibly by helping transduce survival signals triggered by
tonic or basal BCR activation. While B cells deficient in PDK1
show a slight reduction in transcription of the NF-kB target genes
Bcl-xl and Bcl-2, they exhibit a profound reduction in the
expression of Foxo target genes such as Aicda, Rag1, Bcl2l11, and
p27/Kip, as seen in the BCR-deleted B cells [26]. Moreover, B cells
deficient in PDK1 undergo increased apoptosis after they up-
regulate surface IgM at the immature B cell stage. Finally, we
demonstrate a requirement for PDK1 in BCR induced activation
of NF-kB leading to B cell activation and activated B cell survival.
These results establish PDK1 as a regulator of B cell survival by
mediating PI3K signaling to both NF-kB and Foxo transcription
factors.
Materials and Methods
Mice and B Cell Isolation
C.129P2-Cd19tm1(cre)Cgn/J (CD19-Cre mice) [27] were back-
crossed 10 times with C57BL/6 mice. Pdk1flox/flox mice [28] were
bred with the CD19-Cre mice, and offspring were bred with
Pdk1flox/flox mice to generate CD19-Cre+Pdk1flox/flox and CD19-
Cre+Pdk1+/+ mice. All mice were backcrossed with C57BL/6 mice
for at least 6 generations and all mice were kept in pathogen–free
conditions in the animal care facility at Columbia University (New
York, New York) and GIST (Gwangju, Korea). All mice
experiments were approved by Institutional Animal Care and
Use Committee of Columbia University and GIST. Splenic B cells
were isolated from normal C57BL/6 mice by negative depletion of
non-B cells to a purity of greater than 95%.
Cell Culture and Antibodies
Isolated primary B cells were cultured in Bruff’s media
supplemented with 5% FBS. Anti-PDK1 antibody was purchased
from Upstate. Anti-IkBa antibody was purchased from Santa
Cruz. Anti-JNK antibody was purchased from Cell signaling.
Phosphoantibodies for JNK at T183/Y185 and p38 MAPK at
T180/Y182 were purchased from Cell Signaling. Anti-mouse IgM
was purchased from Jackson Laboratory. APC-conjugated anti-
mouse IgM, FITC-conjugated anti-mouse CD43, PerCP-conju-
gated anti-mouse CD25, FITC-conjugated anti-mouse CD117,
APC-conjugated anti-mouse CD19, PE-conjugated anti-mouse
thy1, PE-conjugated-mouse CD4, PerCP-conjugated anti-mouse
CD4, APC-conjugated mouse CD8a, PE-conjugated anti-mouse
thy1, APC-conjugated anti-mouse B220, and PE-Cy5-conjugated
anti-mouse B220 antibodies were purchased from ebiosciences.
Anti-PKCb2 was purchased from Abcam. Anti-HA was purchased
from Sigma. Anti-Myc was purchased from Invitrogen.
In Vivo Reconstitution
Bone marrow cells from bone marrow of CD19-Cre+Pdk1flox/flox
and CD19-Cre+Pdk1+/+ mice were injected into the veins of the
unirradiated Rag1 knockout recipient mice. Recipient mice were
sacrificed 6 weeks after transfer. The cell suspension from bone
marrow and spleen of recipient mice was stained with fluorophore
conjugated antibodies and were analyzed flow cytometry.
Immunohistochemistry
Spleens were fixed with 4% neutral-buffered formalin and
embedded in paraffin. Sections were cut, deparaffinized, and
developed in the immunostaining system, using the VECTORH
M.O.M.TM Immunodetection Kit (Vector Laboratory).
Flow Cytometry
Lymphocytes were isolated from the bone marrow, spleens, and
lymph nodes of 6–9 week old mice. Cell viability was assessed by
annexin V and 7-amino-actinomycin D staining according to the
manufacturer’s protocols (BD-Pharmingen). Stained cells were
analyzed on a FACSCalibur.
Retrovirus Transduction
Phoenix-Eco cells were transfected with pMSCV-Cre-IRES-
GFP retroviral vector and recombinant retroviruses were harvest-
ed 2 days later after the transfection. Total splenocytes were
isolated from wild type mice or Pdk1flox/flox mice and were
stimulated with LPS at 10 mg/ml for 24 hours. After stimulation
splenocytes were infected with Cre-expressing recombinant retro-
viruses by spin infection. Briefly, splenocytes were pretreated with
polybrene for 45 min and the medium was removed. The cells
were then incubated with medium containing recombinant
retroviruses and polybrene for 45 min and were centrifuged for
another 90 min at 2,200 rpm. After centrifugation, virus-contain-
ing medium was removed and cells were cultured in fresh medium
for the indicated time. Infected cells were analyzed by FACS.
Immunoprecipitation
Primary B cells were isolated from C57BL/6 mice and the
isolated 56107 B cells were stimulated with anti-IgM for the
indicated time period. The cells were lysed in 1% TritonX-100
lysis buffer containing 20 mM Tris-HCl (pH 7.4), 150 mM NaCl,
1 mM Na3VO4, and protease inhibitors. Total cell lysates were
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cleared by centrifugation at 14,000 rpm for 10 min at 4uC. From
the cleared lysate, PDK1 protein was immunoprecipitated with
anti-PDK1 antibodies. IPs were washed four times with lysis
buffer, and analyzed.
Results
B Cell Specific Pdk1 Gene Deletion Dramatically Reduces
B Cell Numbers in the Periphery
Based on findings in T cell development and function [8,9], we
hypothesized that PDK1 would also play an important role in B
cells. To investigate the role of PDK1 in B cell development,
survival and function, we crossed mice in which Pdk1 was flanked
by loxP sites (Pdk1flox/flox) with mice expressing Cre recombinase
under control of the CD19 promoter (CD19-cre mice) to delete
Pdk1 from B cells during bone marrow development. We first
analyzed the peripheral B cell population by flow cytometry. As
shown in Figure 1, A and B, both the percentage and number of
B220 positive peripheral B cells was dramatically reduced in B cell
specific Pdk1 knockout mice, compared with wild type littermate
controls. In addition, the size of both the spleen and peripheral
lymph nodes was reduced in B cell specific Pdk1 knockout mice
compared to wild type littermate controls (Figure 1C). While B cell
numbers are severely reduced by Pdk1 gene deletion, the reduction
of B cells in the spleen does not lead to a gross alteration of splenic
structure (Figure 1D). B cells remain in the B cell zone, albeit in
dramatically reduced numbers. We also found that the peripheral
B cells remaining in PDK1 conditional knockout mice express
PDK1 at levels similar to or higher than that of wild type
littermate controls. Therefore, remaining peripheral B cells
escaped CD19-Cre mediated PDK1 deletion.
PDK1 is Required for B Cell Survival Beginning at the
Immature Stage
Next, we sought to determine the developmental stage at which
PDK1 deficient B cells were arrested. Using flow-cytometry, we
examined different populations representing key stages of B cell
development, including stem cell (B2202CD117+), pro-B cell
(B220+CD252CD43+), pre-B cell (B220+CD25+CD432), imma-
ture B cell (B220+IgMhiIgDlo), and mature circulating B cell
(B220+IgMloIgDhi) populations (Figure 2A). We did not notice any
apparent change in the stem cell or progenitor cell populations in
the bone marrow of CD19-Cre+Pdk1flox/flox mice. The total B220+
population in the bone marrow of B cell specific Pdk1 knockout
mice was slightly reduced compared with wild type littermate
controls (Data not shown). However, the percentage of pro-B cell,
and pre-B cells in the bone marrow exhibited no significant
differences between B cell specific Pdk1 knockout mice and
littermate controls (Figure 2A).
In contrast to the B cell populations of early developmental
stages, immature B cell populations (B220+IgMhiIgDlo) in the bone
marrow of PDK1 deficient mice were reduced compared to wild
type controls (6.961.6% versus 9.560.8%). Further analysis using
IgM and IgD surface markers showed that the circulating mature
B cell population (B220+IgMloIgDhi) was reduced significantly
compared to wild type bone marrow (3.460.9 versus 10.560.6%).
In addition, our data showed that the B cell numbers in Pdk1
knockout mice are dramatically reduced after the immature B cell
stage, i.e. following expression of surface IgM (Figure 2B).
To confirm that these results were not attributable to inefficient
deletion of the Pdk1 gene, B cell populations from each
developmental stage were sorted by flow-cytometry and PDK1
expression was determined by western blotting. We loaded cell
lysates derived from same number of cells from each population
(Figure 2C). Although the total protein recovered from each
population differed, likely attributable to differences in cell size,
protein recovery was comparable in CD19-Cre+Pdk1fl/f and wild
type mice. Using GAPDH as a loading control, we checked the
down-regulation of the PDK1 protein level in B cells populations
of different developmental stages. In CD19-Cre+Pdk1fl/f mice,
PDK1 protein levels were reduced from the pro-B cell
(CD19+CD252CD43+) stage, but the reduction of PDK1 protein
level was not dramatic. This might be caused by incomplete
deletion of Pdk1 gene by CD19-Cre in pro-B cell stage. However,
at the pre-B cell (CD19+CD25+CD432) stage, PDK1 protein
levels were significantly reduced (Figure 2C). Even though the
PDK1 protein level was reduced in cells of the pro-B cell stage
from Pdk1 knockout mice, we could not detect any apparent
accumulation of B cells at the specific stage of B cell development.
Thus, reduction of the IgM+ B cell population in Pdk1 knockout
mice might be caused by loss of the population through apoptosis
or proliferative defect.
Defects in B Cell Development Resulting from Pdk1 Gene
Deletion are B Cell Autonomous
Our observations demonstrate that PDK1 is required for B cell
development. However, given that CD19 may be expressed in
other cell types, it is possible that Pdk1 was deleted in cells other
than B cells [29]. To rule out the possibility of off-target Pdk1
deletion affecting B cells development, we performed adoptive
transfer experiments by reconstituting non-irradiated Rag1
deficient recipient mice with bone marrow cells from wild type
and CD19-Cre+Pdk1fl/f mice. Analysis of reconstituted hosts 6
weeks after transfer demonstrated that recipients that had received
wild-type bone marrow reconstituted the pre–B cell and immature
B cell compartments (Figure 3). In hosts reconstituted with CD19-
Cre+Pdk1fl/f bone marrow, there was an almost complete absence
of IgM-positive B cells. In addition to bone marrow, peripheral B
cell numbers in recipient mice reconstituted with CD19-
Cre+Pdk1fl/f bone marrow were significantly lower compared to
mice reconstituted with wild type bone marrow (Figure 3). These
findings parallel those obtained by direct analysis of B cell specific
Pdk1 knockout mice and indicate that the observed phenotypes
were due to an intrinsic defect of PDK1 deficient B cells.
PDK1 is Essential for Survival of IgM+ B Cells
Although the IgM-positive B cell population including imma-
ture and mature B cells in bone marrow was significantly reduced
by Pdk1 gene deletion, it was unclear whether this was caused by
defective proliferation or excessive cell death of the IgM-positive
population. To differentiate between these possibilities, we
investigated the cell cycle status at different development stages
using DNA content analysis. We found that the percentage of cells
in the G2/M stage was considerably greater in B cell populations
from CD19-Cre+Pdk1fl/f mice compared to wild type littermate
controls (Supplementary Figure 1). This could be due to hyper-
proliferation of B cells that escaped CD19-Cre mediated deletion,
owning to the increased availability of niches due to loss of Pdk1
deleted cells. We also analyzed the apoptosis status of each
population of B cells using annexin-V and 7AAD staining. We
found that apoptosis was increased in B cell populations after the
IgM-positive immature B cell stage in CD19-Cre+Pdk1fl/f mice,
while apoptosis of pre-B cells appeared unchanged (Figure 4A).
Consistent with changes in B cell populations in the bone marrow
of CD19-Cre+Pdk1fl/f mice (Figure 2A), the apoptotic population is
more dramatically increased in the mature B cell population
compared with the immature B cell population (Figure 4A).
PDK1 in B-Cell Receptor Survival Signaling
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Foxo is a well-known target of the PI3K/AKT pathway and it is
PDK1 that mediates activation of AKT downstream of PI3K. We,
therefore, suspected that the defect in survival of IgM+ B cells
might be due to a failure to inactivate Foxo upon deletion of
PDK1. Thus, we tested whether Foxo target genes are differen-
tially regulated after Pdk1 gene deletion in IgM+ B cells. Indeed,
Pdk1 gene deletion in bone marrow IgM+ B cell population
dramatically increased expression of the Foxo target genes Aicda,
Rag1, Bcl2l11, and p27/Kip (Figure 4B). However, NF-kB target
genes such as Bcl-2 and Bcl-xl were not dramatically down-
regulated in bone marrow IgM+ B cells after Pdk1 deletion
(Figure 4B).
Peripheral B cell numbers were also dramatically reduced in
CD19-Cre+Pdk1fl/f mice, and the remaining peripheral B cells
exhibited PDK1 protein levels similar to B cells from wild type
mice (data not shown) indicating that these cells evaded CD19-Cre
mediated deletion of Pdk1. In spleen, we found that the mature B
cell population is more severely decreased similar to the bone
marrow of CD19-Cre+Pdk1fl/f mice and CD19+, but IgM- B cell
population is increased (Supplemental Figure 2). In both the spleen
and peripheral lymph nodes, apoptosis of B cell populations was
increased in CD19-Cre+Pdk1fl/f mice (Figure 4C). It has been
reported that the deletion process mediated by CD19-Cre continues
after B cells travel from the bone marrow to the periphery [27].
Therefore, it is likely that a significant proportion of peripheral B
cells from CD19-Cre+Pdk1fl/f mice eventually undergo CD19-Cre
mediated deletion of the Pdk1 gene, and this de-novo deletion of
Pdk1 in peripheral B cells could result in apoptosis. Consistent with
this hypothesis, induction of Cre gene expression in mature B cells
using recombinant retrovirus infection dramatically reduced B cell
survival (Figure 4D).
PDK1 is Essential for B Cell Receptor-mediated B Cell
Activation
As PDK1 is required for B cell survival after the bone
marrow immature B cell stage, i.e. after B cells express surface
BCR (IgM) that is essential for B cell survival and subsequent
maintenance, we speculated that PDK1 is required for BCR
mediated survival of B cells. Therefore, we further investigated
the role of PDK1 in BCR induced signal transduction.
Figure 1. Peripheral B cell numbers are dramatically reduced in B cell specific Pdk1 knockout mice. (A) Flow cytometric analyses were
performed with lymphocytes from spleen and lymph nodes of CD19-Cre+PDK1+/+(+/+) and CD19-Cre+PDK1flox/flox (flox/flox) mice. The FACS plots
shown are representative of five different experiments. (B) The number of B220+ cells in spleen and lymphnode of CD19-Cre+PDK1+/+ and CD19-
Cre+PDK1flox/flox mice (n = 5 mice) presented as mean 6 SD. (C) Spleen and lymph nodes from CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice. (D)
Structure of Spleen from CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice. Paraffin-embedded spleen sections from CD19-Cre+PDK1+/+ and CD19-
Cre+PDK1flox/flox mice were stained by hematoxylin and eosin (top panel) or anti-B220 (bottom panel).
doi:10.1371/journal.pone.0055378.g001
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Although the best way to study this would have been to use the
Pdk1 deficient B cells, rapid apoptosis of B-cells lacking Pdk1
required the use of an alternate approach.
Inducible translocation of the BCR and associated signaling
molecules to lipid rafts is essential for efficient BCR triggered
signaling and activation of B cells. Therefore, we first tested
whether PDK1 is localized to the lipid rafts during BCR
activation. We prepared lipid raft fractions following anti-IgM or
control IgG treatment, and PDK1 localization to lipid rafts was
determined using immunobloting analysis. It is known that IKK is
also localized to the lipid raft fraction upon BCR signaling [16],
and therefore we used IKK as a marker for BCR-induced lipid raft
localization. We consistently detected IKK enriched in the lipid
raft fraction upon stimulation. We also observed that PDK1 was
enriched in the lipid raft fraction of splenic B cells following anti-
IgM treatment (Supplemental Figure 3). Therefore these data
indicate that PDK1 is recruited to lipid rafts after BCR ligation
and is possibly involved in BCR signaling.
Figure 2. PDK1 deficiency blocks B cell development at the immature B cell stage. (A) Flow cytometric analyses of surface markers of B cell
lineage development of bone marrow cells from CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice. The FACS plots shown are representative of five
different experiments. (B) The number of each B cell lineage cell in bone marrow of CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice (n = 5 mice)
presented as mean 6 SD. (C) PDK1 deletion was confirmed by immunoblot analysis after sorting of the indicated populations. Total cell lysate of
0.46106 cells from each population was loaded for this analysis.
doi:10.1371/journal.pone.0055378.g002
PDK1 in B-Cell Receptor Survival Signaling
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The chemical compound 3-hydroxyanthranilic acid (3-HAA)
has been reported to act as a specific inhibitor of PDK1 kinase
activity [30]. Therefore, to circumvent our inability to obtain
viable PDK1 deficient B cells for biochemical analysis, we used 3-
HAA treated B cells to test the role of PDK1 in BCR signal
transduction. Inhibition of PDK1 kinase activity was confirmed by
defective phosphorylation of the T308 site on AKT after BCR
ligation (Figure 5A), a process that is widely accepted to be
mediated by PDK1 [3,4]. On the other hand, treatment of B cells
with 3-HAA did not affect BCR-induced phosphorylation of AKT
S473 (Figure 5A), an event that is believed to be carried out by the
mTOR pathway [6]. Therefore, these results demonstrated that 3-
HAA specifically inhibits PDK1 kinase activity. We then tested the
effect of 3-HAA on activation of the NF-kB pathway, as indicated
by IkBa degradation, in B-cells treated with anti-IgM. While IkB
degradation was clearly inhibited (Figure 5B), the two other major
downstream signaling pathways induced by BCR ligation, the
JNK and p38 MAPK pathways, were not affected by 3-HAA
treatment. This specific inhibition of the NF-kB pathway following
BCR engagement indicates that 3-HAA treatment does not induce
Figure 3. The defect of B cell development in CD19-Cre+PDK1flox/flox mice is caused by B cell intrinsic defects. Bone marrow cells of
CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice were transferred into unirradiated Rag1 deficient recipients. Six weeks after transfer, flow
cytometric analyses of B cell surface markers were performed with bone marrow cells, spleen cells and lymph node cells from the recipient mice. This
is representative of two independent experiments.
doi:10.1371/journal.pone.0055378.g003
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gross abnormalities in B cell signaling, and suggests the
impairment of the NF-kB pathway is caused specifically by
inhibition of PDK1. It has been reported that 3-HAA treatment of
T cells only affects TCR-mediated NF-kB activation and AKT
phosphorylation at T308 [30], similar to the results obtained here
in B cells.
Figure 4. PDK1 is essential for B cell survival after bone marrow immature B cell stage. (A) Flow cytometric analyses of apoptosis (as
indicated by Annexin V staining) were performed with bone marrow cells of CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice. The histograms
shown were gated as indicated on the right of each plot. Apoptotic percentage of each B cell lineage in bone marrow of CD19-Cre+PDK1+/+ and
CD19-Cre+PDK1flox/flox mice (n = 4 mice) presented as mean 6 SD. Numbers indicate the percentage of 7AAD and annexin V–double positive cells
(top), annexin V–positive cells (right bottom) or 7AAD–annexin V–negative cells (left bottom). (B) Foxo target genes (Aicda, Rag1, Bcl2l11 and p27/Kip)
and NF-kB target genes (Bcl-2 and Bcl-xl) expression levels in IgM-positive bone marrow B cells were analyzed by quantitative RT-PCR analysis as
described in the Materials and Methods. Data are presented as mean6 SD (*p,0.05, **p,0.01). (C) Flow cytometric analyses of apoptosis markers on
B220+ B cells were performed with spleen and PLN cells of CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice. Data are representative of two
independent experiments. (D) Primary B cells were stimulated with LPS and were then infected with Cre expressing retrovirus (MSCV-Cre IRES GFP).
The ratio of GFP-positive to GFP-negative B cell one day after infection was set to 1. Each following day the ratios were checked by flow-cytometry.
The experiment was done in triplicate and data are presented as mean 6 SD. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0055378.g004
PDK1 in B-Cell Receptor Survival Signaling
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BCR-antigen engagement activates B cells and this activation
induces up-regulations of surface activation markers including
CD69 and CD86, which are involved in lymphocyte attachment
and antigen presentation, respectively. Our data shows that the
inactivation of PDK1 abolished the up-regulation of surface
activation markers (Figure 5C), consistent with an essential role for
PDK1 in BCR induced NF-kB activation. Together with the
failure of survival of B cells lacking PDK1, these data indicate that
PDK1 is an important mediator of BCR-mediated B cell
activation.
PDK1 is Required for NF-kB Activation and NF-kB-
mediated B Cell Survival
We next investigated how PDK1 functions in the NF-kB
activation pathway in B-cells. Previous studies have indicated that
NF-kB activation can be induced by BCR ligation via the PKCb-
CARMA1 cascade [17,18]. We have previously reported that
PDK1 is essential for optimal TCR/CD28 induced NF-kB
activation through the PDK1-PKCh-CARMA1 pathway [8].
Therefore, we wanted to test whether PDK1 might also interact
with PKCb, which is the PKC isoform in B cells used to activate
the NF-kB pathway. Using co-immunoprecipitation, we found
that PDK1 binds to PKCb, when both proteins are over expressed
in HEK293 cells (Figure 6A). In addition, PKCb, binds to PDK1
in primary B cells after stimulation with anti-IgM (Figure 6B).
Moreover, we found that PDK1 and PKCb, enhanced CBM-
mediated NF-kB activation, but kinase inactive PDK1 did not
(Figure 6C). Therefore, NF-kB activation during BCR signaling
can be mediated by PDK1-PKCb, activation pathway.
Therefore, in BCR induced signaling, PDK1 is specifically
involved in activation of AKT and the NF-kB pathway, both of
which are known to be involved in cell survival via regulation of
the expression and activity of anti-apoptotic BCL2 family
members. As mentioned before, BCL-xL plays an important role
in survival of B cells and is induced upon BCR ligation. We found
that up-regulation of BCL-xL induced by BCR activation can also
Figure 5. PDK1 is essential for B cell activation. (A) Phosphorylation of AKT at T308 and S473 in primary B cells stimulated with AffiniPure
F(ab9)2 fragment goat anti-Mouse IgM and with or without 3-HAA were analyzed by immunoblot anlaysis. (B) Phosphorylation of JNK and p38 MAPK
and IkBa degradation in primary B cells stimulated with anti-IgM antibody and with or without 3-HAA were analyzed by immunobloting analysis. (C)
Flow cytometric analyses of B cell activation markers (CD69 and CD86) were performed with primary B cells stimulated with anti-IgM antibody for 24
hours and with or without 3-HAA. Numbers indicate the percentage of CD69 or CD86 positive cells. DMSO was used for the vehicle control. (A), (B)
and (C) are representative of three independent experiments.
doi:10.1371/journal.pone.0055378.g005
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be blocked by 3-HAA treatment (Figure 6D). In addition, we
found that NF-kB activation is directly linked with activated B cell
survival. Treatment with NF-kB inhibitor peptide affects activated
B cell survival while the peptide did not affect resting B cell
survival (Figure 6E). However, 3-HAA treatment severely affected
both resting and activated B cell survival (Figure 6E). These results
suggest that PDK1 contributes to survival of B cells stimulated
through the BCR by mediating activation of NF-kB and AKT
pathways and that PDK1 is essential for survival of resting B cells
primarily by mediating activation of AKT.
Discussion
In T cells, PDK1 has been shown to be a crucial intermediate
kinase in the CD28-PI3K pathway, responsible for integrating the
TCR and CD28 signaling pathways and allowing their synergistic
activation of NF-kB [8]. Engagement of the TCR complex leads
to the recruitment of CD28 to the cSMAC region and consequent
interaction of CD28 with its ligand, B7. Activated TCR signaling
complexes recruit PKCh, whereas CD28, through PI3K-generat-
ed PtdIns(3,4,5)P3, recruits and activates PDK1. PDK1 not only
interacts with and activates PKCh, but also interacts with
CARMA1, thereby allowing PKCh to phosphorylate CARMA1,
a crucial step in the subsequent assembly of the CBM complex and
activation of the NF-kB pathway. Other TCR-CD28–mediated
signals, including Jnk, p38 and NFAT pathways, are not affected
by PDK1.
BCR signaling resembles TCR mediated signaling in many
ways. Cross-linking of the BCR also leads to phosphorylation of
ITAMs, those of Iga and Igb, and activation of proximal signaling
molecules including Syk and PI3K. These proximal signaling
molecules, in turn, activate downstream signaling pathways
including PKCb, JNK, p38 MAPK, NF-kB, and AKT pathways.
In this report, to understand the role of PDK1 in BCR induced
signal transduction, we tried to achieve B cell specific deletion of
Pdk1 in Pdk1flox/flox mice using CD19-Cre; however, extensive loss
of B cells beginning in the immature B cell stage precluded
purification of PDK1 deficient mature B cells for further studies.
Therefore, we used a chemical inhibitor that specifically blocks
PDK1 activity to examine the role of PDK1 in BCR-induced
signaling pathways. We found that, upon BCR stimulation, PDK1
is relocated to lipid rafts and is involved in activation of the NF-kB
pathway, but not in the activation of JNK and p38 MAPK
pathways. We also found that PDK1 can bind to PKCb in
activated B cells. Our data suggest that upon BCR ligation, PDK1
participates in activation of PKCb. We speculate that these events
lead to activation of NF-kB pathway, in a manner similar to what
occurs in T cells following TCR ligation. We also found that
PDK1 is involved in BCR-induced activation of the AKT pathway
through phosphorylation of T308 of AKT, while the other major
phosphorylation site (S473) of AKT is not impacted by the
inhibition of PDK1. The T308 site is located on the activation
loop of AKT, and the S473 site is located on the hydrophobic
motif. It has been reported that the T308 site is regulated by
PDK1 [3,4], while the S473 site is regulated by mTOR-rictor [6].
Therefore, our data suggests that PDK1 plays a crucial role in
mediating antigen receptor induced signal transduction in B cells
in a manner that is similar to the role of PDK1 in T cells.
In this report, we provide convincing evidence that PDK1 is
essential for B cell survival. However we could not clearly define
the effect of PDK1 on early B cell development. The timing of the
cre-induced Pdk1 gene deletion in this model did not allow us to
assess the role of PDK1 in pre-B cell differentiation. Complete
deletion of PDK1 leads to excessive apoptosis and loss of B cells
beginning at the immature B cell stage, following up-regulation of
surface IgM. Interestingly, although PDK1 is the downstream
target of PI3K, PDK1 deficiency, as assessed by PDK1 protein
levels in sorted cells, does not appear to affect pre-B cell survival.
We found that the remaining peripheral B cells in CD19-
Cre+Pdk1flox/flox mice had escaped Pdk1 deletion. Nevertheless,
CD19-Cre+Pdk1flox/flox peripheral B cells exhibited dramatically
increased apoptosis. It seems likely that continuous peripheral
CD19-Cre-mediated deletion [27] of the Pdk1 gene in escaped B
cells was the cause of the observed increase in apoptosis.
Consistent with this hypothesis, we found that deleting Pdk1 by
retrovirus-mediated Cre expression also reduced survival in
peripheral B cells. These results further support the notion that
PDK1 is essential for B cell survival beyond the bone marrow
immature stage.
Basal BCR induced signaling, triggered either through an
antigen-dependent positive selection process, or through an
antigen independent ‘‘tonic’’ signaling process, is crucial for B
cell development and survival beyond the immature stage.
Recently it has been shown that this survival signal is mediated
by the PI3K pathway, largely through regulation of Foxo
transcription factors and, in part, through NF-kB [26]. We found
that B cell survival becomes dependent on PDK1 after B cells
enter the immature B cell stage and up-regulate their surface IgM/
BCR complex. In the IgM+ B cell, the NF-kB target gene
expression is slightly down-regulated by Pdk1 deletion which
suggest that PDK1 is involved in basal BCR-mediated NF-kB
activation. However, even though PKCb and CARMA1 are
involved in BCR-mediated NF-kB activation during the B cell
activation, the PKCb [31] and CARMA1 [32] knockout mice
show normal survival of resting B cells. Recent data suggested that
the ‘‘tonic’’ signaling that is required for resting B cell survival is
mediated by regulation of Foxo, but not by NF-kB activation [26].
Consistent with these data we found that Foxo target gene
expression was increased in IgM+ B cells. Furthermore, NF-kB
inhibition had little effect on resting B cell survival. Therefore,
PDK1 mediates resting B cell survival through its well known
function as a key signaling intermediate in PI3K/AKT signaling.
In contrast to the situation in resting B cells, NF-kB blockade
dramatically reduced the survival of activated B cells. These data
suggests that in these cells, activation of NF-kB may also be an
important function of PDK1. Such a model is entirely consistent
Figure 6. 3-HAA (PDK1 inhibitor) inhibits B cell receptor-meditated NF-kB activation. (A) HEK293 cell were transfected with plasmids for
expression of Myc-PDK1 and HA-PKCb or HA-PKCh, the cell lysates were then analyzed for the binding between PDK1 and PKCb or PKCh by
immunoprecipitation and immunoblotting. In the construct for expression of HA-PKCb or HA-PKCh, internal ribosome entry site (IRES) sequence and
GFP open reading frame (ORF) is integrated after the PKC ORF. Thus, GFP expression level was used for internal control. (B) The B cells stimulated with
anti-IgM were analyzed for the binding between PDK1 and PKCb by immunoprecipitation and immunoblotting. (C) Luciferase assay with reporter
plasmids containing NF-kB binding sites. Expression plasmids of PDK1, PKCb, or CARMA1-Bcl10-Malt1 (CBM) were cotransfected as indicated. Data are
presented as mean 6 SD. (D) Bcl-xl gene expression was analyzed through quantitative RT-PCR analysis. Data are presented as mean 6 SD. (E) Flow
cytometric analyses of apoptosis markers were performed with primary B cells stimulated with or without anti-IgM antibody and with 3-HAA, NF-kB
inhibitor peptide (NBD peptide) or DMSO. Numbers indicate the percentage of 7AAD and annexin V–double positive cells (top), annexin V–positive
cells (right bottom) or 7AAD–annexin V–negative cells (left bottom). (A), (B), (C), (D) and (E) were representative of two to three experiments.
doi:10.1371/journal.pone.0055378.g006
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with previous data demonstrating that deletion of either PKCb
and CARMA1, essential components of the signaling pathway
from BCR to NF-kB, only affect the activated B cell survival.
Therefore, while PDK1-mediated NF-kB activation is required for
survival of activated B cell (strong BCR activation), PDK1-
mediated regulation of Foxo could be required for survival of
resting B cell (weak BCR activation). The contribution of Foxo to
PDK1-mediated survival signals in activated B cells is unclear, but
it can be surmised from previous studies that proliferation
following BCR activation will also be dependent on PDK1-
induced regulation of Foxo [33]. In summary, our results suggest
that PDK1 plays a critical role in B-cells, by helping transduce
BCR signals that are essential for the regulation of both NF-kB
and Foxo transcription factors and thus PDK1 is required for the
survival of resting and activated B cells.
Supporting Information
Figure S1 Flow cytometric analyses of the cell cycle
(7AAD staining) were performed with bone marrow cells
of CD19-Cre/PDK1+/+ and CD19-Cre/PDK1flox/flox mice.
The histograms shown were gated for IgM+B220+ cells. The area
parameter histogram was used to determine the percentage of cells
in sub-G1/G0 (first area), G1/G0 (second area), S (third area), and
G2/M (fourth area) phases.
(AI)
Figure S2 Flow cytometric analyses of surface markers
of B cells in spleen cells from CD19-Cre+PDK1+/+ and
CD19-Cre+PDK1flox/flox mice. The bottom dot plots shown
were after gating by CD19+.
(AI)
Figure S3 Redistribution of PDK1 to lipid raft after
BCR stimulation. Primary B cells were stimulated with anti-
IgM antibody or IgG control and were then lysed with 1% Triton
X-100 (Sigma) and subjected to sucrose density gradient
centrifugation to isolate lipid rafts. The distribution of PDK1 in
lipid and non-raft fraction was assessed by immunoblotting.
(AI)
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